1Rouauh JP, Falette N, Guehenneux F, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway [J], Nat Genet, 1996, 14(4) : 482-486.
2Kawakubo H, Carey JL, Brachtel E, et al. Expression of the NF-kappa B-responsive gene BTG2 is aberrantly regulated in breast cancer[J], Oncogene, 2004, 23 (50) : 8310-8319.
3Ramus S J, Bobrow LG, Pharoah PD, et al. Increased frequencyof TP53 mutation in BRCAI and BRCA2 ovarian tumours[J].Genes Chromosomes Cancer, 1999, 25 : 91-96.
4Wiechen K. Diatchenko L, Agoulnik A, et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene [J]. Am J Pathol, 2001 , 159 ( 5 ) :1635-1643.
5Chung CM, Man C, Jin Y, et al. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells[J]. Mol Carcinog, 2005, 43 (3) :165-174.
6Hu W, Kavanagh JJ, Dearer M, et al. Frequent overexpression of STKIS/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer[J].Oncol Res,2005, 15 ( 1 ) : 49-57.
7Liu Q, Kaneko S, Yang L, et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215[J]. J Biol Chem, 2004, 279(50) : 52175-52182.
8Luo LY, Katsaros D, Scorilas A, et al. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis[J]. Cancer Res, 2003,63 (4) :807-811.
9Shayesteh L,Lu Y,Kuo WL,et al. PIK3CA is implicated as an oncogene in ovarian cancer[J]. Nat Genet, 1999, 21 ( 1 ) : 99-102,
10Amanda P J, Campbell IG,Leet C, et al, The phosphatidylinositol 3-kinase p85 a gene is an oncogene in human ovarian and colon tumors[J]. Cancer Res,2001,61 (10) : 7426-7429.
7Lloyd Ko, Yin BW. Synthesis and secrtion of the ovarian cancer antigen CA125 by the human cancer cell line NIH: OVCAR - 3 [ J ]. Turnour Biol, 2001,22 (2) :77 - 82.
8Duly MJ, Bonfrer JM, Kulpa J, et al. CA125 in ovarian can cer : Europe - an Group on Tumor Markers guidelines for clinical use[J]. Int J Gynecol Cancer, 2005, 15(5) :679 -691.
9Meyer T, Rustin GJ. Role of tamour markers in monitoring epitheiouarian cancer [J]. Br J Cancer, 2000, 82(9) :1535 - 1538.
10Bast RC Jr, Badgwell D, Lu Z, et al. New tumor markers: CA125 and Beyond[ J]. Int J Gynecol Cancer, 2005,15 ( 3 ) : 274 - 281.
